| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/28/2006 | WO2006102099A2 ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP |
| 09/28/2006 | WO2006102095A2 Framework-shuffling of antibodies |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006101692A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 09/28/2006 | WO2006101691A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | WO2006101000A1 Anti-dermatan sulfate antibody and functional sulfated oligosaccharide |
| 09/28/2006 | WO2006100681A2 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 09/28/2006 | WO2006100679A2 Recombinant antibodies against human type ii transglutaminase and uses thereof |
| 09/28/2006 | WO2006100582A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | WO2006100449A1 Improvements in or relating to treatment and prevention of viral infections |
| 09/28/2006 | WO2006100430A2 Polypeptides |
| 09/28/2006 | WO2006100257A2 Vaccine and antibodies against parasitic nematodes |
| 09/28/2006 | WO2006100033A1 Method for identifying cell-specific protein combination patterns |
| 09/28/2006 | WO2006099875A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | WO2006099747A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | WO2006099698A2 Novel anti-plgf antibody |
| 09/28/2006 | WO2006086396A3 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/28/2006 | WO2006085913A3 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 09/28/2006 | WO2006077101A3 Ager-peptides and use thereof |
| 09/28/2006 | WO2006069403A3 Methods for producing soluble multi-membrane-spanning proteins |
| 09/28/2006 | WO2006061258A3 Cytotoxic agents comprising new taxanes |
| 09/28/2006 | WO2006046042B1 Method of selecting polypeptides |
| 09/28/2006 | WO2006023629A3 Treatment of pediatric multiple sclerosis |
| 09/28/2006 | WO2005104835A3 Transgenic animals and uses thereof |
| 09/28/2006 | WO2005054434A3 Use of notch pathway interfering agents for treatment of plasma cell disorders |
| 09/28/2006 | WO2005034732A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/28/2006 | WO2004104173A3 Ovr115 ANTIBODY COMPOSITION AND METHODS OF USE |
| 09/28/2006 | WO2004046330A3 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 09/28/2006 | WO2004024090A3 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 09/28/2006 | WO2003057857A3 Antibodies directed to pdgfd and uses thereof |
| 09/28/2006 | WO2003057841A3 Remote homologues and kinases and methods of detection |
| 09/28/2006 | WO2002083872A3 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060218659 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060216809 cGMP-binding, cGMP-specific phosphodiesterase materials and methods |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | US20060216769 Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects |
| 09/28/2006 | US20060216767 Docetaxel immunoassay |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216719 Novel short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216709 Midkine-like protein |
| 09/28/2006 | US20060216703 Extraction and concentration method |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216303 Processes and products with modified antibodies of human milk fat globule specificity |
| 09/28/2006 | US20060216300 Recombinant antibodies and compositions and methods for making and using the same |
| 09/28/2006 | US20060216298 Plasmodium falciparum antigens inducing protective antibodies |
| 09/28/2006 | US20060216296 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/28/2006 | US20060216293 TNFalpha-neutralizing antibodies |
| 09/28/2006 | US20060216291 Glycoprotein VI and uses thereof |
| 09/28/2006 | US20060216290 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (Par1) |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216287 EPH-like receptor protein tyrosine kinases |
| 09/28/2006 | US20060216285 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/28/2006 | US20060216284 free of a denaturing reagent and comprising of an antibody that binds to a respiratory syncytial virus (RSV) antigen, a human metapneumovirus (hMPV) antigen, integrin alpha v beta 3, CD2, CD19, an Eph receptor, or to IL-9 |
| 09/28/2006 | US20060216282 administering antibodies or fragments that binds to kit proteins (glycoprotein receptor protein-tyrosine kinase), to inhibit the kinase enzymatic reactions and to inhibit the stem cell factor signal transduction; treatment of skin disorders, asthma, inflammation, anaphylaxis, bronchospasm and tumors |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | US20060216235 Monoclonal antibody or cellular cytotoxicity inducing ligand that competitively inhibits binding of isolated monoclonal antibody encoded by clone accession number PTA-5643 to its target antigen |
| 09/28/2006 | US20060216234 Cancerous disease modifying antibodies |
| 09/28/2006 | US20060216233 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/28/2006 | CA2602956A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | CA2602790A1 Docetaxel immunoassay |
| 09/28/2006 | CA2602375A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | CA2602316A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 09/28/2006 | CA2602035A1 Framework-shuffling of antibodies |
| 09/28/2006 | CA2602028A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | CA2601858A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | CA2601400A1 Improvements in or relating to treatment and prevention of viral infections |
| 09/28/2006 | CA2601267A1 Novel anti-plgf antibody |
| 09/27/2006 | EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1705251A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF a1,6-FUCOSYLTRANSFERASE |
| 09/27/2006 | EP1705191A2 Anti-interleukin-18 antibody |
| 09/27/2006 | EP1705186A1 Vaccine and antibody against Dictyocaulus viviparus |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1704166A2 M-csf-specific monoclonal antibody and uses thereof |
| 09/27/2006 | EP1703917A2 Heh4 molecules and uses thereof |
| 09/27/2006 | EP1703893A2 Novel anti-il 13 antibodies and uses thereof |
| 09/27/2006 | EP1703887A2 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 09/27/2006 | EP1703806A1 Method for improving body weight uniformity and increasing carcass yield in animals |
| 09/27/2006 | EP1461062B1 Composition and method for treating chronic allograft rejection |
| 09/27/2006 | EP1335936B1 Hypha-specific factors from candida albicans |
| 09/27/2006 | EP1307560B1 Schizophrenia related gene and protein |
| 09/27/2006 | EP1000162B1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE |
| 09/27/2006 | EP0770628B1 Reconstituted human antibody against human interleukin-8 |
| 09/27/2006 | CN1839205A Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 09/27/2006 | CN1839201A Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 09/27/2006 | CN1839157A Antibodies against interleukin-22 and uses therefor |